Zum Hauptinhalt springen

Exercise habits and factors associated with exercise in systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.

Azar, M ; Rice, DB ; et al.
In: Disability and rehabilitation, Jg. 40 (2018-08-01), Heft 17, S. 1997-2003
academicJournal

Titel:
Exercise habits and factors associated with exercise in systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.
Autor/in / Beteiligte Person: Azar, M ; Rice, DB ; Kwakkenbos, L ; Carrier, ME ; Shrier, I ; Bartlett, SJ ; Hudson, M ; Mouthon, L ; Poiraudeau, S ; van den Ende CHM ; Johnson, SR ; Rodriguez Reyna, TS ; Schouffoer, AA ; Welling, J ; Thombs, BD
Zeitschrift: Disability and rehabilitation, Jg. 40 (2018-08-01), Heft 17, S. 1997-2003
Veröffentlichung: 2015- : Abingdon, Oxford : Taylor & Francis ; <i>Original Publication</i>: London ; Washington, DC : Taylor & Francis, c1992-, 2018
Medientyp: academicJournal
ISSN: 1464-5165 (electronic)
DOI: 10.1080/09638288.2017.1323023
Schlagwort:
  • Adult
  • Anxiety etiology
  • Anxiety prevention & control
  • Cohort Studies
  • Depression etiology
  • Depression prevention & control
  • Fatigue etiology
  • Fatigue prevention & control
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pain etiology
  • Pain prevention & control
  • Self Report
  • Surveys and Questionnaires
  • Disabled Persons psychology
  • Disabled Persons rehabilitation
  • Exercise physiology
  • Exercise psychology
  • Physical Fitness physiology
  • Physical Fitness psychology
  • Scleroderma, Systemic physiopathology
  • Scleroderma, Systemic psychology
  • Scleroderma, Systemic rehabilitation
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Corporate Authors: SPIN investigators
  • Publication Type: Journal Article; Research Support, Non-U.S. Gov't
  • Language: English
  • [Disabil Rehabil] 2018 Aug; Vol. 40 (17), pp. 1997-2003. <i>Date of Electronic Publication: </i>2017 May 08.
  • MeSH Terms: Disabled Persons* / psychology ; Disabled Persons* / rehabilitation ; Exercise* / physiology ; Exercise* / psychology ; Physical Fitness* / physiology ; Physical Fitness* / psychology ; Scleroderma, Systemic* / physiopathology ; Scleroderma, Systemic* / psychology ; Scleroderma, Systemic* / rehabilitation ; Adult ; Anxiety / etiology ; Anxiety / prevention & control ; Cohort Studies ; Depression / etiology ; Depression / prevention & control ; Fatigue / etiology ; Fatigue / prevention & control ; Female ; Humans ; Male ; Middle Aged ; Pain / etiology ; Pain / prevention & control ; Self Report ; Surveys and Questionnaires
  • Grant Information: Canada CIHR
  • Contributed Indexing: Investigator: M Baron, McGill University, Montréal, Québec, Canada.; D Furst, University of California, Los Angeles, CA, USA.; K Gottesman, Scleroderma Foundation, Los Angeles, CA, USA.; F van den Hoogen, Radboud University Medical Center and Sint Maartenskliniek, Nijmegen, the Netherlands.; V Malcarne, San Diego State University, San Diego, CA, USA.; MD Mayes, University of Texas McGovern School of Medicine, Houston, TX, USA.; WR Nielson, St. Joseph’s Health Care, London, Ontario, Canada.; R Riggs, Scleroderma Foundation, Danvers, MA, USA.; M Sauve, Scleroderma Society of Ontario, Hamilton, Ontario, Canada.; F Wigley, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; S Assassi, University of Texas McGovern School of Medicine, Houston, TX, USA.; I Boutron, Université Paris Descartes, and Assistance Publique-Hôpitaux de Paris, Paris, France.; AC Maia, University of Minho, Braga, Portugal.; G El-Baalbaki, Université du Québec à Montréal, Montréal, Québec, Canada; C Ells, McGill University, Montréal, Québec, Canada.; K Fligelstone, Scleroderma Society, London, UK.; C Fortune, Scleroderma Society of Ontario, Hamilton, Ontario, Canada.; T Frech, University of Utah, Salt Lake City, UT, USA.; D Godard, Association des Sclérodermiques de France, Sorel-Moussel, France.; D Harel, New York University, New York, NY, USA.; A Impens, Midwestern University, Downers Grove, IL, USA.; Y Jang, McGill University, Montréal, Québec, Canada.; AT Kennedy, Federation of European Scleroderma Associations, Dublin, Ireland.; M Larche, McMaster University, Hamilton, Ontario, Canada.; C Leite, University of Minho, Braga, Portugal.; C Marra, Memorial University, St. John’s, Newfoundland, Canada.; K Nielsen, Scleroderma Society of Ontario, Hamilton, Ontario, Canada.; JL Poole, University of New Mexico, Albuquerque, New Mexico, USA.; J Pope, University of Western Ontario, London, Ontario, Canada.; A Portales, Asociación Española de Esclerodermia, Madrid, Spain.; RJ Steele, Jewish General Hospital and McGill University, Montréal, Québec, Canada.; ME Suarez-Almazor, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; D Wong-Rieger, Canadian Organization for Rare Disorders, Toronto, Ontario, Canada.; A Albert, Université Laval, Québec, Canada.; G Arsenault, Sherbrooke University, Sherbrooke, Québec, Canada.; L Bissonnette, Sherbrooke University, Sherbrooke, Québec, Canada.; G Boire, Sherbrooke University, Sherbrooke, Québec, Canada.; A Bruns, Sherbrooke University, Sherbrooke, Québec, Canada.; P Carreira, Servicio de Reumatologia del Hospital 12 de Octubre, Madrid, Spain.; L Chung, Stanford University, Stanford, CA, USA.; P Dagenais, Sherbrooke University, Sherbrooke, Québec, Canada.; C Denton, Royal Free London Hospital, London, UK.; R Domsic, University of Pittsburgh, Pittsburgh, PA, USA.; JV Dunne, St. Paul’s Hospital and University of British Columbia, Vancouver, British Columbia, Canada.; P Fortin, Université Laval, Québec, Québec, Canada.; A Gill, Royal Free London Hospital, London, UK.; J Gordon, Hospital for Special Surgery, New York City, NY, USA.; G Gyger, Jewish General Hospital and McGill University, Montréal, Québec, Canada.; AL Herrick, University of Manchester, Salford Royal NHS Foundation Trust, Manchester, UK.; M Hinchcliff, Northwestern University, Chicago, Illinois, USA.; A Ikic, Université Laval, Québec, Québec, Canada.; N Jones, University of Alberta, Edmonton, Alberta, Canada.; AJBF Fernandes, Sherbrooke University, Sherbrooke, Québec, Canada.; S Kafaja, University of California, Los Angeles, CA, USA.; N Khalidi, McMaster University, Hamilton, Ontario, Canada.; B Korman, Northwestern University, Chicago, IL, USA.; P Liang, Sherbrooke University, Sherbrooke, Québec, Canada.; J Manning, Salford Royal NHS Foundation Trust, Salford, UK.; A Masetto, Sherbrooke University, Sherbrooke, Québec, Canada.; D Robinson, University of Manitoba, Winnipeg, Manitoba, Canada.; S Roux, Sherbrooke University, Sherbrooke, Québec, Canada.; D Smith, University of Ottawa, Ottawa, Ontario, Canada.; R Spiera, Hospital for Special Surgery, New York, NY, USA.; V Steen, Georgetown University, Washington, DC, USA.; E Sutton, Dalhousie University, Halifax, Nova Scotia, Canada.; C Thorne, Southlake Regional Health Centre, Newmarket, Ontario, Canada.; J Varga, Northwestern University, Chicago, Illinois, USA.; P Wilcox, St. Paul’s Hospital and University of British Columbia, Vancouver, British Columbia, Canada.; VC Delisle, Jewish General Hospital and McGill University, Montréal, Québec, Canada.; C Fodoruk, Jewish General Hospital, Montréal, Québec, Canada.; RS Fox, San Diego State University and University of California, San Diego, San Diego, CA, USA.; S Gholizadeh, San Diego State University and University of California, San Diego, San Diego, CA, USA.; LR Jewett, Jewish General Hospital and McGill University, Montréal, Québec, Canada.; B Levis, Jewish General Hospital and McGill University, Montréal, Québec, Canada.; SD Mills, San Diego State University and University of California, San Diego, San Diego, CA, USA.; MR Pepin, Jewish General Hospital, Montréal, Québec, Canada.; J Persmann, Université du Québec à Montréal, Montréal, Québec, Canada ; Keywords: SPIN; Scleroderma; exercise; exercise habits; systemic sclerosis
  • Entry Date(s): Date Created: 20170509 Date Completed: 20181022 Latest Revision: 20190703
  • Update Code: 20240513

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -